Executed by an interdisciplinary, world-class team with deep experience in RNA and structural biology, artificial intelligence, machine learning, genomics, engineering, and physics, we are THE RNA structure company.
Ron Dror,
Computational Biology and Machine Learning
Professor of Computer Science, Stanford University
Leads research group that uses molecular simulation and machine learning to elucidate biomolecular structure, dynamics, and function.
Roger Kornberg,
Structural Biology and RNA
Professor of Structural Biology, Stanford University
Nobel prize in Chemistry for understanding the molecular basis of eukaryotic transcription.
Gene Yeo,
RNA Biology and RNA Therapeutics
Professor of Cellular and Molecular Medicine, UCSD
His research focuses on the importance of RNA processing and the roles that RNA binding proteins play in development and disease.
Nicholas Meanwell,
Drug Hunter and Medicinal Chemist
Former Scientific VP of Small Molecule Drug Discovery at Bristol-Myers Squibb
Advanced 33 clinical candidates over a 40-year career at BMS
Percy Carter,
Drug Discovery Leader and Biotech Executive
CSO of Blueprint Medicines and Board member of HiFiBiO Therapeutics
Previous scientific leadership roles at Fibrogen, Janssen, and BMS
